Yasaman Taslimi
Warning message
- Could not find a Solr index corresponding to your website and environment. To fix this problem, please read our documentation.
- Could not find a Solr index corresponding to your website and environment. To fix this problem, please read our documentation.
Researcher Pasteur Institute of Iran, Iran Email: ytaslimi@yahoo.com
VALIDATE Role: Network Associate
Research Keywords: Leishmaniasis
Biography: Since 2000, I have been working in the Immunotherapy and Leishmania Vaccine Research Department at the Pasteur Institute of Iran. During my 24 years of experience, I have contributed to diverse research projects that have encompassed diagnostic methods, the design of DNA and live vaccines against leishmaniasis, and the evaluation of drug efficacy. My M.Sc. research focused on the use of Leishmania tarentolae as a live therapy to deliver IP-10 (Interferon gamma inducible protein 10) to a mice model of breast cancer. Our research revealed that non-pathogenic live vaccines may be a potent and efficacious strategy for vaccination, particularly for different types of leishmaniasis. I am delighted to share my research findings and expertise with other VALIDATE members. In recent years, my focus has been on non-invasive sampling and point-of-care diagnosis techniques for cutaneous leishmaniasis (CL). CL primarily impacts underprivileged populations in developing countries that have limited access to financial and healthcare resources. Our objective is to facilitate rapid, painless, and safe diagnosis of the disease using the current non-invasive technique, particularly for children and patients with lesions in sensitive areas of their body, such as the face. We are enthusiastic about disseminating the methodology to all research or medical centres grappling with CL diagnosis challenges.
Key Publications:
|